European Patent Office Affirms Revocation Of Viagra Patent

Law360, New York (February 10, 2005, 12:00 AM EST) -- A generic version of Pfizer’s erectile-dysfunction drug Viagra will reach the shelves of European drug stores after the European Patent Office decided to revoke a method-of-use patent for the drug, capping a seven-year battle between Pfizer and rival drug makers.

In a blow to Pfizer, the EPO affirmed its earlier decision to revoke Pfizer's method-of-use patent containing claims for the use of any PDE inhibitor for the manufacture of an oral treatment for erectile dysfunction.

The ruling was made following a three-day hearing by a Board...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.